Employees: 02 (2023.0)Legal category: 5485Size: PMECreation date: 2013-01-28 (13 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: HEGENHEIM (68220), Haut-Rhin
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE DE HEGENHEIM : revenue, balance sheet and financial ratios
PHARMACIE DE HEGENHEIM is a French company
founded 13 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in HEGENHEIM (68220),
this company of category PME
shows in 2025 a net income positive of 76 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DE HEGENHEIM (SIREN 791255409)
Indicator
2025
2024
2023
2022
2020
2019
2018
2017
2016
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net income
76 474 €
103 587 €
108 991 €
109 310 €
111 926 €
98 549 €
98 289 €
92 035 €
72 924 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2025, PHARMACIE DE HEGENHEIM generates positive net income of 76 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2025: 73 k€ -> 76 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
76 474 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 50%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 60%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
49.962%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
59.714%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE DE HEGENHEIM
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2022
2023
2024
2025
Debt ratio
392.204
252.258
181.803
136.672
102.707
61.63
53.099
51.192
49.962
Financial autonomy
17.198
23.878
31.852
38.156
44.609
55.574
60.546
59.453
59.714
Repayment capacity
None
None
None
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
49.962025
2023
2024
2025
Q1: 13.71
Med: 49.76
Q3: 129.07
Average+8 pts over 3 years
In 2025, the debt ratio of PHARMACIE DE HEGENHEIM (49.96) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
59.71%2025
2023
2024
2025
Q1: 33.42%
Med: 53.71%
Q3: 72.08%
Good-7 pts over 3 years
In 2025, the financial autonomy of PHARMACIE DE HEGENHEIM (59.7%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 395.06. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
395.062
Liquidity indicators evolution PHARMACIE DE HEGENHEIM
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2022
2023
2024
2025
Liquidity ratio
153.138
156.203
156.745
166.215
206.376
257.513
396.076
367.963
395.062
Interest coverage
None
None
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
395.062025
2023
2024
2025
Q1: 131.03
Med: 182.29
Q3: 258.7
Excellent
In 2025, the liquidity ratio of PHARMACIE DE HEGENHEIM (395.06) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
Positioning of PHARMACIE DE HEGENHEIM in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of PHARMACIE DE HEGENHEIM is estimated at
1 214 798 €
(range 824 368€ - 1 906 186€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
824k€1214k€1906k€
1 214 798 €Range: 824 368€ - 1 906 186€
NAF 5 année 2025
Valuation method used
Net Income Multiple
76 474 €
×
15.9x
=1 214 799 €
Range: 824 368€ - 1 906 186€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DE HEGENHEIM with other companies in the same sector:
Frequently asked questions about PHARMACIE DE HEGENHEIM
What is the revenue of PHARMACIE DE HEGENHEIM ?
The revenue of PHARMACIE DE HEGENHEIM is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMACIE DE HEGENHEIM profitable?
Yes, PHARMACIE DE HEGENHEIM generated a net profit of 76 k€ in 2025.
Where is the headquarters of PHARMACIE DE HEGENHEIM ?
The headquarters of PHARMACIE DE HEGENHEIM is located in HEGENHEIM (68220), in the department Haut-Rhin.
Where to find the tax return of PHARMACIE DE HEGENHEIM ?
The tax return of PHARMACIE DE HEGENHEIM is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DE HEGENHEIM operate?
PHARMACIE DE HEGENHEIM operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart